AYTU 8-K 2026-09-22

AYTU BIOPHARMA, INC (AYTU) 8-K dated 2026-09-22 — accession 0001437749-26-030900. This URL is the filing, not the AYTU hub.

AYTU BIOPHARMA, INC (AYTU) is a drug manufacturers - specialty & generic company listed on US.

AYTU: SECURITIES AND EXCHANGE COMMISSION

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. Revenue was down 18.0% from 2024-06-30 to 2025-06-30. AYTU currently screens at market cap $24.1M.

Not investment advice. The AYTU SEC hub lists recent forms. The stock page is the research view.